CELLULAR IMMUNITY TO HUMAN BASIC MYELIN PROTEIN IN WOMEN WITH DYSPLASIA AND CARCINOMA IN SITU OF THE CERVIX
- 1 October 1975
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 82 (10), 820-825
- https://doi.org/10.1111/j.1471-0528.1975.tb00580.x
Abstract
Sensitization to human myelin basic protein or encephalitogenic factor (EF), and antigen thought to be analogous to different human tumours, can be measured by the macrophage migration inhibition test (MMI). The MMI test was done on one occasion in 51 women with dysplasia and carcinoma in situ of the cervix; 20 women with non-malignant gynaecological conditions served as controls. Sensitization to EF was found in 71 per cent of women with carcinoma in situ and 42 per cent of women with dysplasia. None of the controls showed sensitization. Sensitization could not be related to histological evidence for cellular infiltration within the cervix.Keywords
This publication has 7 references indexed in Scilit:
- Immune response to adenovirus 12-induced tumour antigens, as measured in vitro by the macrophage migration inhibition testEuropean Journal of Cancer (1965), 1973
- A Common Tumour Specific AntigenBritish Journal of Cancer, 1973
- Migration Inhibition Experiments with Mixtures of Human Lymphocytes and Guinea Pig Peritoneal Exudate CellsInternational Archives of Allergy and Immunology, 1973
- LYMPHOCYTE SENSITISATION: AN IN-VITRO TEST FOR CANCER ?The Lancet, 1970
- The histology and cytology of changes in the epithelium of the cervix uteriJournal of Clinical Pathology, 1969
- Delayed Hypersensitivity in VitroThe Journal of Immunology, 1964
- In vitro Cell Migration as a Model for Delayed Hypersensitivity.Experimental Biology and Medicine, 1962